Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.62B |
| 2 |
Aon
AON
|
+$1.04B |
| 3 |
iShares Core MSCI EAFE ETF
IEFA
|
+$901M |
| 4 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$823M |
| 5 |
Pinduoduo
PDD
|
+$770M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.19B |
| 2 |
Datadog
DDOG
|
+$747M |
| 3 |
TSMC
TSM
|
+$707M |
| 4 |
Baxter International
BAX
|
+$703M |
| 5 |
Estee Lauder
EL
|
+$592M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 24.96% |
| 2 | Technology | 19.28% |
| 3 | Healthcare | 10.85% |
| 4 | Financials | 9.95% |
| 5 | Consumer Discretionary | 8.38% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
226
Vanguard FTSE Europe ETF
VGK
$29.8B
| $825M | 0.09% |
13,529,134
-204,431
| -1% | -$12.2M |
2013 Q2
39 quarters
|
|
227
Altria Group
MO
$125B
| $823M | 0.09% |
18,440,659
+1,335,374
| +8% | +$61.4M |
2013 Q2
39 quarters
|
|
228
Steris
STE
$21.7B
| $811M | 0.09% |
4,240,540
+484,086
| +13% | +$93.6M |
2013 Q2
39 quarters
|
|
229
Micron Technology
MU
$994B
| $809M | 0.09% |
13,405,461
-780,329
| -6% | -$45.7M |
2013 Q2
39 quarters
|
|
230
iShares Core S&P US Growth ETF
IUSG
$33.3B
| $804M | 0.09% |
9,052,057
+813,792
| +10% | +$69.3M |
2013 Q2
39 quarters
|
|
231
Chubb
CB
$139B
| $798M | 0.09% |
4,108,194
+69,777
| +2% | +$14.7M |
2013 Q2
39 quarters
|
|
232
Dow Inc
DOW
$21.6B
| $794M | 0.09% |
14,483,785
-943,028
| -6% | -$53.1M |
2019 Q2
15 quarters
|
|
233
GE Aerospace
GE
$326B
| $780M | 0.08% |
10,225,838
-3,843,086
| -27% | -$257M |
2013 Q2
39 quarters
|
|
234
SLB Ltd
SLB
$73.5B
| $772M | 0.08% |
15,713,386
+620,704
| +4% | +$33M |
2013 Q2
39 quarters
|
|
235
Marriott International
MAR
$101B
| $771M | 0.08% |
4,644,199
-167,046
| -3% | -$27.8M |
2013 Q2
39 quarters
|
|
236
Monster Beverage
MNST
$89.6B
| $762M | 0.08% |
28,224,610
+2,325,138
| +9% | +$59.6M |
2013 Q2
39 quarters
|
|
237
Vanguard Short-Term Inflation-Protected Securities Index Fund
VTIP
$20.6B
| $760M | 0.08% |
15,902,340
-435,491
| -3% | -$20.5M |
2013 Q2
39 quarters
|
|
238
Moderna
MRNA
$87B
| $760M | 0.08% |
4,950,573
+763,220
| +18% | +$126M |
2018 Q4
17 quarters
|
|
239
Microchip Technology
MCHP
$40.1B
| $756M | 0.08% |
9,024,141
+151,601
| +2% | +$12.1M |
2013 Q2
39 quarters
|
|
240
McKesson
MCK
$117B
| $755M | 0.08% |
2,119,207
-33,374
| -2% | -$12.1M |
2013 Q2
39 quarters
|
|
241
Verisk Analytics
VRSK
$24.8B
| $752M | 0.08% |
3,917,357
+151,649
| +4% | +$27.5M |
2013 Q2
39 quarters
|
|
242
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$17.8B
| $751M | 0.08% |
9,936,804
+259,067
| +3% | +$19.4M |
2013 Q2
39 quarters
|
|
243
Regeneron Pharmaceuticals
REGN
$81.4B
| $750M | 0.08% |
912,276
+22,898
| +3% | +$17.3M |
2013 Q2
39 quarters
|
|
244
State Street Consumer Staples Select Sector SPDR ETF
XLP
$14.6B
| $748M | 0.08% |
10,010,618
-4,562,418
| -31% | -$334M |
2013 Q2
39 quarters
|
|
245
IQVIA
IQV
$43.9B
| $742M | 0.08% |
3,730,337
-86,451
| -2% | -$18.5M |
2013 Q2
39 quarters
|
|
246
Vertex Pharmaceuticals
VRTX
$127B
| $741M | 0.08% |
2,353,061
-225,383
| -9% | -$67.6M |
2013 Q2
39 quarters
|
|
247
W.R. Berkley
WRB
$28B
| $736M | 0.08% |
17,737,497
+1,388,857
| +8% | +$62.1M |
2013 Q2
39 quarters
|
|
248
Teleflex
TFX
$5.53B
| $732M | 0.08% |
2,891,657
+200,465
| +7% | +$48.6M |
2013 Q2
39 quarters
|
|
249
Novo Nordisk
NVO
$171B
| $732M | 0.08% |
9,205,432
-1,219,364
| -12% | -$86.5M |
2013 Q2
39 quarters
|
|
250
iShares MBS ETF
MBB
$35.9B
| $729M | 0.08% |
7,700,663
+529,695
| +7% | +$50M |
2013 Q2
39 quarters
|
|
Similar funds
Morgan Stanley's Q1 2023 Portfolio in Review
As of Q1 2023, Morgan Stanley held 8,043 positions worth $933B, up 5.9% from $880B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Morgan Stanley's Q1 2023 filing shows 162 new, 3,525 increased, 3,121 reduced and 296 closed positions. Its largest new stake was Calvert US Large-Cap Diversity, Equity and Inclusion Index ETF: 400,000 shares worth $20.8M. The largest sale was Apple, an estimated $1.19B.
By sector, the portfolio is most concentrated in Miscellaneous at 25% of assets, up from 25% a quarter earlier, followed by Technology and Healthcare.
- Morgan Stanley's largest Q1 2023 buy was Calvert US Large-Cap Diversity, Equity and Inclusion Index ETF: 400,000 shares worth $20.8M.
- Morgan Stanley added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $1.62B increase.
- Morgan Stanley's biggest Q1 2023 reduction was Apple, cutting an estimated $1.19B.
- Morgan Stanley fully exited SVB Financial Group in Q1 2023, selling an estimated $354M.
- Morgan Stanley's ten largest holdings make up 16% of its $933B portfolio in Q1 2023.
- Morgan Stanley opened 162 new positions and closed 296 in Q1 2023.
- Morgan Stanley's portfolio value rose 5.9% quarter-over-quarter to $933B.
Based on Morgan Stanley's 13F filing for Q1 2023, filed 15 May 2023.